Tracey A. Waddelow

Statistics

Publications

Citations

378

H-Index

Active since

2001

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Tracey A. Waddelow is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, cancer immunotherapy, and immunotherapy.

Publications per year

2001–2003

Publications

Mylotarg? (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation

Francis J. Giles, H. Kantarjian, Steve Kornblau et al. · Cancer · 2001 · 281 citations

Medicine, Hematology, Oncology +15

Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNFα levels during treatment

Apostolia M. Tsimberidou, Tracey A. Waddelow, Hagop M. Kantarjian et al. · Leukemia Research · 2003 · 76 citations

Life Sciences, Immunology, Oncology +16

Intravenous Corticosteroids to Reduce Gemtuzumab Ozogamicin Infusion Reactions

Francis J. Giles, Jörge E. Cortes, Terri A Halliburton et al. · Annals of Pharmacotherapy · 2003 · 21 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

1–3 of 3